🔎 Trials Near Me

Acasă › Leucemie limfoblastică acută › New York

Studii clinice pentru Leucemie limfoblastică acută în New York

32 studii pentru Leucemie limfoblastică acută caută participanți în New York.

Orașe în New York

Text oficial al studiului (în engleză)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Queens Hospital Center, Jamaica
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Stony Brook University Medical Center, Stony Brook
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
Vârste de la 40 la 75 · Toate sexele · Actualizat 2 oct. 2026 · NCT05334069

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

  • Memorial Sloan Kettering Cancer Center, New York
În curs de recrutareFaza 1
Vârste de la 12 la 78 · Toate sexele · Actualizat 29 sept. 2026 · NCT03802695

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

  • Memorial Sloan Kettering Cancer Center -- Pediatrics, New York
În curs de recrutareFaza 2
6 Months · Toate sexele · Actualizat 28 sept. 2026 · NCT06514794

Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children

  • Columbia University Medical Center, New York
În curs de recrutareStudiu observațional
4 Weeks – 18 Years · Toate sexele · Actualizat 24 sept. 2026 · NCT06529575

Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

  • Montefiore Einstein Comprehensive Cancer Center, The Bronx
În curs de recrutareFaza 1/2
Vârste de 18 ani și peste · Toate sexele · Actualizat 23 sept. 2026 · NCT06308588

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

  • Montefiore Medical Center, New York
În curs de recrutareFaza 1/2
30 Days · Toate sexele · Actualizat 16 sept. 2026 · NCT04065399

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

  • The Mount Sinai Hospital, New York
În curs de recrutareFaza 1
Vârste de la 0 la 18 · Toate sexele · Actualizat 16 sept. 2026 · NCT06173518

Cord Blood Transplant in Adults With Blood Cancers

  • Memorial Sloan Kettering Cancer Center, New York
În curs de recrutareFaza 2
Vârste de la 21 la 65 · Toate sexele · Actualizat 11 sept. 2026 · NCT05884333

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

  • Memorial Sloan Kettering Cancer Center, New York
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 1 sept. 2026 · NCT07586618

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Albany Medical Center, Albany
  • Maimonides Medical Center, Brooklyn
  • NYU Langone Hospital - Long Island, Mineola
  • și încă 7
În curs de recrutareFaza 1/2
Până la vârsta de 22 · Toate sexele · Actualizat 25 aug. 2026 · NCT04726241

A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia

  • Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • și încă 1
În curs de recrutareFaza 2
Vârste de 40 ani și peste · Toate sexele · Actualizat 20 aug. 2026 · NCT07400029

A Study of CTD402 in T-ALL/LBL Patients

  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Einstein Comprehensive Cancer Center, The Bronx
În curs de recrutareFaza 1/2
Vârste de 1 ani și peste · Toate sexele · Actualizat 19 aug. 2026 · NCT07070219

MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence

  • Roswell Park Cancer Institute, Buffalo
În curs de recrutareVoluntari sănătoși bineveniți
Toate vârstele · Toate sexele · Actualizat 12 aug. 2026 · NCT06323044

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

  • Research Site, New York
În curs de recrutareFaza 1/2
Vârste de 16 ani și peste · Toate sexele · Actualizat 20 iul. 2026 · NCT07155226

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Roswell Park Cancer Institute, Buffalo
  • North Shore University Hospital, Lake Sucess
  • Cohen Children's Medical Center of New York, New Hyde
  • și încă 9
În curs de recrutareStudiu observațional
Toate vârstele · Toate sexele · Actualizat 6 iul. 2026 · NCT01351545

A Study of Revumenib and Mezigdomide in People With Leukemia

  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • și încă 1
În curs de recrutareFaza 1/2
Vârste de 12 ani și peste · Toate sexele · Actualizat 22 iun. 2026 · NCT07356154

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

  • Memorial Sloan Kettering Cancer Center, New York
În curs de recrutareFaza 1/2
Până la vârsta de 1 · Toate sexele · Actualizat 3 iun. 2026 · NCT05848687

European Prospective Investigation Into Childhood Cancer

  • Columbia University Irving Medical Center, New York
În curs de recrutareStudiu observațional
Vârste de la 3 la 21 · Toate sexele · Actualizat 2 iun. 2026 · NCT05375617

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
  • University of Rochester, Rochester
  • Stony Brook University Medical Center, Stony Brook
  • și încă 1
În curs de recrutareStudiu observațional
Toate vârstele · Toate sexele · Actualizat 18 mai 2026 · NCT01790152

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
În curs de recrutareFaza 2
Până la vârsta de 26 · Toate sexele · Actualizat 14 mai 2026 · NCT07566377

A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

  • Ascentage Investigative Site #1160, Stony Brook
  • Ascentage Investigative Site #1151, The Bronx
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 30 apr. 2026 · NCT06051409

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

  • Roswell Park Comprehensive Cancer Center, Buffalo
În curs de recrutare
Vârste de la 3 la 9 · Toate sexele · Actualizat 23 apr. 2026 · NCT06074666

Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)

  • The Mt. Hope Family Center, Rochester
În curs de recrutare
Vârste de la 8 la 17 · Toate sexele · Actualizat 8 apr. 2026 · NCT06956781

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  • Roswell Park Comprehensive Cancer Center, Buffalo
În curs de recrutareFaza 1/2
Vârste de 12 ani și peste · Toate sexele · Actualizat 24 mar. 2026 · NCT04988555

A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

  • University of Rochester Medical Center, Wilmot Cancer Center, Rochester
În curs de recrutareFaza 1/2
Vârste de 18 ani și peste · Toate sexele · Actualizat 18 mar. 2026 · NCT06207123

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • Memorial Sloan Kettering Cancer Center, New York
În curs de recrutareFaza 2
Vârste de la 18 la 54 · Toate sexele · Actualizat 17 mar. 2026 · NCT06918431

A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)

  • Memorial Sloan Kettering Cancer Suffolk-Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • și încă 1
În curs de recrutareFaza 1
Vârste de 17 ani și peste · Toate sexele · Actualizat 10 feb. 2026 · NCT06287528

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

  • Memorial Sloan Kettering Cancer Center, New York
În curs de recrutareFaza 1
Vârste de 12 ani și peste · Toate sexele · Actualizat 8 ian. 2026 · NCT04872478

A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors

  • Columbia University Medical Center, New York
În curs de recrutare
Vârste de la 5 la 21 · Toate sexele · Actualizat 7 oct. 2025 · NCT05963971

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

  • Memorial Sloan Kettering Cancer Center, New York
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 15 apr. 2025 · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Children's Hospital New York-Presbyterian, New York
  • Memorial Sloan Kettering Cancer Center, New York
În curs de recrutareFaza 1
Vârste de la 1 la 21 · Toate sexele · Actualizat 6 dec. 2024 · NCT05476770

Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.